//fpnotebook.com/
Nevirapine
Aka: Nevirapine, Viramune, NVP- See Also
- Class
- Efficacy
- Good benefit in combination with 2 nucleosides
- Dosing
- Start: 200 mg PO qd for 14 days
- If no rash, increase dose to 200 mg PO bid
- Adverse effects
- See NNRTI for class related adverse effects
- Severe hepatoxicity and liver failure risk if pre-treatment CD4 >250 in men or >400 in women
- References
Medication Costs | ||
---|---|---|
nevirapine (on 4/19/2017 at Medicaid.Gov Pharmacy Drug pricing) | ||
NEVIRAPINE 200 MG TABLET | Generic | $0.19 each |
NEVIRAPINE ER 400 MG TABLET | Generic | $10.46 each |
viramune (on 1/4/2017 at Medicaid.Gov Pharmacy Drug pricing) | ||
VIRAMUNE 200 MG TABLET | Generic | $0.19 each |
VIRAMUNE XR 400 MG TABLET | Generic | $10.46 each |
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information. |
Nevirapine (C0132326) |
|
---|---|
Definition (NCI) | A benzodiazepine non-nucleoside reverse transcriptase inhibitor. In combination with other antiretroviral drugs, nevirapine reduces HIV viral loads and increases CD4 counts, thereby retarding or preventing the damage to the immune system and reducing the risk of developing AIDS. |
Definition (MSH) | A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS. |
Definition (CSP) | potent, non-nucleoside reverse transcriptase inhibitor used, usually in combination with nucleoside analogs, for treatment of HIV infection and AIDS. |
Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
MSH | D019829 |
SnomedCT | 108704001, 386898005 |
LNC | LP21317-0, MTHU013861 |
English | 6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-, Nevirapine, nevirapine, nevirapine (medication), Nevirapine [Chemical/Ingredient], NEVIRAPINE, 11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, NVP, Nevirapine (product), Nevirapine (substance) |
Swedish | Nevirapin |
Czech | nevirapin |
Finnish | Nevirapiini |
Russian | NEVIRAPIN, НЕВИРАПИН |
Japanese | ネビラピン |
Polish | Newirapina |
Spanish | nevirapina (producto), nevirapina (sustancia), nevirapina, Nevirapina |
French | Névirapine |
German | Nevirapin |
Italian | Nevirapina |
Portuguese | Nevirapina |
Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Viramune (C0728726) |
|
---|---|
Concepts | Pharmacologic Substance (T121) , Nucleic Acid, Nucleoside, or Nucleotide (T114) |
MSH | D019829 |
English | viramune, Viramune |
Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.
If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.
Please Contact Me as you run across problems with any of these versions on the website.